What’s New: Today at the inaugural all.ai 2020 Virtual Summit, Intel India in collaboration with the government of Telangana, International Institute of Information Technology, Hyderabad (IIIT-H) and Public Health Foundation of India (PHFI) announced the launch of INAI, an applied artificial intelligence (AI) research center in Hyderabad. INAI is an initiative to apply AI to population scale problems in the Indian context, with a focus on identifying and solving challenges in the healthcare and smart mobility segments through strong ecosystem collaboration.
“With its unique strengths of talent, technology, data availability, and the potential for population-scale AI adoption, India has this tremendous opportunity to lead human-centric applications and democratize AI for the world. Our aspiration is to make AI synonymous with India as we strive to achieve the true potential of AI in critical segments like healthcare, smart mobility and the future of work by advancing innovation, research, technology and skills.
NEC OncoImmunity AS (NOI), a subsidiary of NEC Corporation (NEC), and Oslo University Hospital (OUH) are pleased to announce that they have recently been awarded a prestigious grant from the Research Council of Norway (RCN) to develop an artificial intelligence (AI) platform that will enable the rapid design of T-cell diagnostics for emerging or endemic infectious diseases. The project will develop a novel T-cell diagnostic for the current COVID-19 pandemic to complement the current serological tests. This will improve the ability to identify immune responses and acquired immunity, which is desperately needed to deal with the COVID-19 crisis.
Current technologies involve extensive trial and error to define exactly which parts of the pathogen induces robust immunity. These so-called immunodominant epitopes need to be identified for the general population. These demanding, work-intensive and time-consuming steps are necessary to develop tests to monitor the T-cell response to viruses such as SARS-CoV-2 (the